Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.55 USD | -4.79% | -10.94% | -23.93% |
May. 23 | Transcript : Theravance Biopharma, Inc. - Special Call | |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
Financials (USD)
Sales 2024 * | 78.81M | Sales 2025 * | 101M | Capitalization | 416M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | 1M | EV / Sales 2024 * | 4.1 x |
Net cash position 2024 * | 93M | Net cash position 2025 * | - | EV / Sales 2025 * | 4.13 x |
P/E ratio 2024 * |
-20.1
x | P/E ratio 2025 * |
41.2
x | Employees | 99 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.36% |
Latest transcript on Theravance Biopharma, Inc.
1 day | -4.79% | ||
1 week | -10.94% | ||
Current month | +1.30% | ||
1 month | -7.27% | ||
3 months | -4.79% | ||
6 months | -17.55% | ||
Current year | -23.93% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 14-05-31 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 14-05-31 |
Eran Broshy
BRD | Director/Board Member | 65 | 14-06-01 |
Director/Board Member | 59 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.03% | 746 M€ | -.--% | - | |
0.02% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 8.55 | -4.79% | 370,830 |
24-05-22 | 8.98 | -1.54% | 237,245 |
24-05-21 | 9.12 | +0.22% | 494,738 |
24-05-20 | 9.1 | -2.05% | 278,563 |
24-05-17 | 9.29 | -3.23% | 278,154 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.93% | 437M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- TBPH Stock